Arena Pharmaceuticals Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Arena Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Arena Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Arena Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Quick Ratio | 8.31 | |
| Fifty Two Week Low | 45.50 | |
| Target High Price | 120.00 | |
| Fifty Two Week High | 100.00 | |
| Target Low Price | 80.00 |
Arena |
Arena Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Arena Pharmaceuticals on January 26, 2024 and sell it today you would earn a total of 100.00 from holding Arena Pharmaceuticals or generate -100.0% return on investment over 90 days. Arena Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Arena, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Arena Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arena Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Arena Pharmaceuticals, and traders can use it to determine the average amount a Arena Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ARNA |
Based on monthly moving average Arena Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arena Pharmaceuticals by adding Arena Pharmaceuticals to a well-diversified portfolio.
Arena Pharmaceuticals Fundamentals Growth
Arena Stock prices reflect investors' perceptions of the future prospects and financial health of Arena Pharmaceuticals, and Arena Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arena Stock performance.
| Return On Equity | -70.3 | |||
| Return On Asset | -34.53 | |||
| Current Valuation | 5.36 B | |||
| Shares Outstanding | 61.56 M | |||
| Price To Earning | 4.53 X | |||
| Price To Book | 7.65 X | |||
| Revenue | 54 K | |||
| EBITDA | (541.79 M) | |||
| Cash And Equivalents | 550.47 M | |||
| Cash Per Share | 8.93 X | |||
| Total Debt | 51.31 M | |||
| Debt To Equity | 0.08 % | |||
| Book Value Per Share | 13.07 X | |||
| Cash Flow From Operations | (452.02 M) | |||
| Earnings Per Share | (9.72) X | |||
| Total Asset | 256.79 M | |||
| Retained Earnings | (1.19 B) | |||
| Current Asset | 174.84 M | |||
| Current Liabilities | 49.9 M | |||
Things to note about Arena Pharmaceuticals performance evaluation
Checking the ongoing alerts about Arena Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arena Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arena Pharmaceuticals is not yet fully synchronised with the market data | |
| Arena Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Arena Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 54 K. Net Loss for the year was (616.43 M) with loss before overhead, payroll, taxes, and interest of (419.45 M). | |
| Arena Pharmaceuticals currently holds about 550.47 M in cash with (452.02 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.93. | |
| Over 84.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Arena Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arena Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Arena Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arena Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arena Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arena Pharmaceuticals' stock. These opinions can provide insight into Arena Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Arena Stock
If you are still planning to invest in Arena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arena Pharmaceuticals' history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |